Evidence map›Paper›PMID 37312999›Full record

ReviewRSC advances2023

Dynamics of reduced graphene oxide: synthesis and structural models.

Edwin T Mombeshora, Edigar Muchuweni

Abstract readReview
In one paragraph

Review in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Edwin T MombeshoraDepartment of Chemistry and Earth Sciences, University of Zimbabwe Mount Pleasant Harare MP167 Zimbabwe mombeshoraet@gmail.com emombeshora@science.uz.ac.zw.ORCID https://orcid.org/0000-0002-8333-9979
Edigar MuchuweniDepartment of Engineering and Physics, Bindura University of Science Education Bindura Zimbabwe.ORCID https://orcid.org/0000-0002-7520-9154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological advancements are leading to an upsurge in demand for functional materials that satisfy several of humankind's needs. In addition to this, the current global drive is to develop materials with high efficacy in intended applications whilst practising green chemistry principles to ensure sustainability. Carbon-based materials, such as reduced graphene oxide (RGO), in particular, can possibly meet this criterion because they can be derived from waste biomass (a renewable material), possibly synthesised at low temperatures without the use of hazardous chemicals, and are biodegradable (owing to their organic nature), among other characteristics. Additionally, RGO as a carbon-based material is gaining momentum in several applications due to its lightweight, nontoxicity, excellent flexibility, tuneable band gap (from reduction), higher electrical conductivity (relative to graphene oxide, GO), low cost (owing to the natural abundance of carbon), and potentially facile and scalable synthesis protocols. Despite these attributes, the possible structures of RGO are still numerous with notable critical variations and the synthesis procedures have been dynamic. Herein, we summarize the highlights from the historical breakthroughs in understanding the structure of RGO (from the perspective of GO) and the recent state-of-the-art synthesis protocols, covering the period from 2020 to 2023. These are key aspects in the realisation of the full potential of RGO materials through the tailoring of physicochemical properties and reproducibility. The reviewed work highlights the merits and prospects of the physicochemical properties of RGO toward achieving sustainable, environmentally friendly, low-cost, and high-performing materials at a large scale for use in functional devices/processes to pave the way for commercialisation. This can drive the sustainability and commercial viability aspects of RGO as a material.

Identifiers

PMID37312999
PMCPMC10258683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.